Michele Negri

Identification and Characterization of Novel NMDA Receptor Antagonists Selective for NR2A- over NR2B-Containing Receptors

Ezio Bettini, Anna Sava, Cristiana Griffante et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 136 citations

6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor

Fabrizio Micheli, Paolo Cavanni, Daniele Andreotti et al. · Journal of Medicinal Chemistry · 2010 · 68 citations · Full text

Pharmacotherapy, New Series, Heterocycle Chemistry +16

1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors

Fabrizio Micheli, Paolo Cavanni, Roberto Arban et al. · Journal of Medicinal Chemistry · 2010 · 51 citations · Full text

Medicinal Chemistry, Heterocyclic, Pharmacological Study +15

GSK356278, a Potent, Selective, Brain-Penetrant Phosphodiesterase 4 Inhibitor That Demonstrates Anxiolytic and Cognition-Enhancing Effects without Inducing Side Effects in Preclinical Species

A. Richard Rutter, Alessandro Poffe, Palmina Cavallini et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 49 citations

Slow dissociation of partial agonists from the D2 receptor is linked to reduced prolactin release

Lucia Carboni, Michele Negri, Francesca Michielin et al. · The International Journal of Neuropsychopharmacology · 2011 · 25 citations